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IV Differentiation to Mature T and B Lymphocytes after
Implantation of Embryoid Bodies into Nude Mice
UNA CHEN* and HOYAN MOK
Basel Institute for Immunology, Grenzacherstrasser 487, CH-4005 Basel, Switzerland
Mouse embryonic stem (ES) cells in culture can differentiate into late stages of many
lineage-committed precursor cells. Under appropriate organ-culture conditions, ES cels
differentiate into lymphoidlike cells at a stage equivalent to lymphoid cells found in fetal
liver. These hematopoietic precursors are located in cup-shaped structures found in some
embryoid bodies; we called such embryoid bodies "ES fetuses." In this study, we have
followed the maturation of hematopoietic cells after implantation of ES fetuses into nude
mice for 3 weeks. ES-cell-derived lymphoid cells-pre-B cells, mature B cells, and mature T
cells were found in all lymphoid organs. Interestingly, there was also an increase of T cells
of host origin. Because native nude mouse lack thymus, these T cells might be educated by
thymuslike epithelium generated from ES fetuses. Practical applications of this combined in
vitro and in vivo system are discussed.
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INTRODUCTION
Mouse embryonic stem (ES) cells in culture can
differentiate into precursor cells committed to many
lineages (Martin, 1981; Doetschman et al., 1985;
Robertson, 1987). We have previously defined cul-
ture conditions favorable for the differentiation of
ES cells into hemat0poietic cells including lym-
phoidlike cells at a stage equivalent to those found
in fetal liver at days 10 to 14 after fertilization.
These hematopoietic precursors are located in cup-
shaped structures found in some embryoid bodies;
we call such embryoid bodies "ES fetuses." Further-
more, using retroviruses and lymphokines, we es-
tablished cell lines containing mixed populations of
hematopoietic precursor cells (Chen, 1992). Some of
these transformed cells were able to differentiate
into mature lymphoid and myeloid cells after injec-
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tion into sublethally irradiated F1 mice (Chen et al.,
1992).
When single-cell suspensions obtained by me-
chanical disruption of ES fetuses were injected into
immuno-incompetent SCID mice, the mice died
within 2 days. Intraperitoneal injection led to the
migration of cells, mainly to liver, and ES-derived
lymphoid precursor cells differentiated into IgM
secreting cells in a limiting-dilution pre-B-cell assay.
When one or two whole embryoid boides were
implanted under the kidney capsule of athymic
nude mice, some mature lymphoid cells were found
in the circulation as well as in situ. These prelimi-
nary observations suggested that ES-cell-derived
hematopoietic precursors require an embryonic mi-
croenvironment for proper development in order to
mature before they can migrate to primary and
peripheral lymphoid organs in adult mice.
We report here that after implantation of ES
fetuses under the skin of athymic nude mice, un-
transformed, mature B and T cells, as well as
myeloid cells, of donor origin are found in the host.
Moreover, the number of host T cells also increased,
implying that the implanted embryoid bodies pro-
vide some thymic function.
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RESULTS
B Lymphocytes of Donor and Host Origin are
Present in Chimeric Nude Mice
To document B-lymphocyte differentiation, ES fe-
tuses were implanted subcutaneously into C57B1/6
nude mice. Host and donor B ceils can be distin-
guished by an allotypic difference of surface IgM.
Three weeks after implantation, single-cell suspen-
sions from bone marrow, lymph nodes, and spleen
of chimeric mice were stained with FITC-labeled
monoclonal antibodies (mAbs) specific for the /a
and fib allotypes of B cells derived from donor and
host, respectively. The proportion of cells positive
for each surface marker, as well as the proportion of
total sIg+B cells, in each organ was estimated by
flow cytometry. Figure 1 shows representative re-
suits of the one out of three experiments. The
percentages of host-derived, donor-derived, and to-
tal B cells are summarized in Table 1.
ES-cell-derived/a positive B cells were found in
bone marrow (BM), lymph nodes (LN), and spleen
(Table 1). The percentage of donor B cells detected
was highly variable; part of this variability may be
related to the particular ES-cell line used as well as
to the time of culture. Although there were fewer
host B cells in the periphery than in control
C57B1/6 nude mice, the level in bone marrow
was comparable. In all locations, the level of total
sIg
/ B cells of chimeric mice was equal to or
higher than the level of sIg B cells in control
nude mice.
In the chimeric nude mice experiments, we found
that the degree of chimerism, that is, the ratio of
mature donor ES-cell-derived B cells to host B cells
changes as a function of the length of culture in
vitro. In preliminary experiments, we established
that no donor B cells could be detected when the ES
fetuses were implanted earlier than 14 days or
longer than 31 days (data not shown). The ratio of
donor to host fl+ B cells was less than 1 when the ES
ES Host lcgativc Total
0 c-Ig
0 0 0 (x-Ig
Spleen
FIGURE 1. Flow cytometric analysis of B cells derived from ES cells (-/’), host (_/b), control (negative), or total (sIg) B cells from bone
marrow (BM), lymph nodes (LN), or spleen. The number in each of the four compartments indicates the percentage of cells of each
individual staining mAb, as indicated on the x-axis and y-axis of ech contour figure. Biotin-labeled (Sieckmann et al., 1991),
biotin-labeled #b (Stall and Loken, 1984), and PE-labeled streptavidin; sIg, FITC-labeled sheep anti-mouse Ig heavy and light chains,
F(ab)d fragment (Silenus, Hawthorotreet, Australia). x 10 cells per mAb staining was performed and a minimum of x 10 cells
were analyzed per sample.UNTRANSFORMED ES LYMPHOCYTES 81
TABLE
B cells of donor and host origin in chimeric mice"
Expt. Origin/ Organ
b Ratio 3a 3b ratio Total B220 Negative
no. conditions (donor) (host) /b (donor) (host) 3a/Sb sIg control
I-1 ES fetuses of line D3 BM 0.4 0.7 0.5 5.5 3.4 1.6 10.2 3.7 0.1
cultured for 20 days LN 10.4 36.8 0.3 13.5 45.9 0.3 72.0 72.5 0.2
Spleen 2.9 29.3 0.1 11.9 33.3 0.4 48.8 50.9 0.3
1-2 BM cells from Expt. I-1 BM 1.1 0.3 3.5 n.d. 0.2 n.d. 4.0 4.7 0.3
5 x 106 cells/mouse, iv LN 61.4 2.3 26.3 n.d. 2.2 n.d. 90.8 95.1 0.1
Spleen 46.5 1.7 27.5 n.d. 2.2 n.d. 52.5 55.2 0.9
II ES fetuses of line D3 BM 1.0 1.4 0.7 11.6 3.6 3.2 2.8 4.7 0.3
cultured for 27 days LN 53.1 1.7 30.5 88.2 1.1 80.1 86.6 90.7 0.1
Spleen 26.3 0.3 87.1 31.2 1.7 18.4 31.2 35.6 0.9
III-1 ES fetuses of line CCE BM 20.0 7.7 2.5 28.7 1.5 19.1 26.5 28.4 0.1
cultured for 20 days LN 60.2 27.7 2.1 63.4 24.6 2.6 89.0 90.0 0.1
(= Fig. 1) Spleen 48.5 25.2 1.9 31.1 16.7 1.8 65.3 69.8 0.1
III-2 BM cells from Expt III-1 BM 3.2 2.3 1.4 n.d. 3.5 n.d. 13.3 9.1 0.4
5 x 106 cells/mouse, iv LN 57.3 5.2 10.9 n.d. 6.0 n.d. 79.5 86.6 0.7
Spleen 51.2 3.9 12.9 n.d. 3.8 n.d. 69.5 70.5 1.1
IV C57B1/6 nu/nu mice BM 0.1 6.6 0.02 1.6 6.8 0.2 7.3 16.6 0.1
(control) LN 0.2 82.7 <0.01 1.2 71.8 <0.01 82.9 88.9 0.4
Spleen 0.1 72.9 <0.01 1.0 85.2 <0.01 80.4 89.3 0.3
V Strain 129 mice BM 1.9 0.2 9.5 1.0 0.4 6.3 2.5 2.8 0.1
(control) LN 47.7 3.0 15.9 49.8 2.4 20.8 52.7 55.6 1.0
Spleen 55.5 1.2 46.3 54.4 0.8 68.0 56.8 56.8 0.1
ES fetuses implantated into C57B1;6 nude mice; weeks later cells anlayzed by flow cytometry and bone cells transferred into secondary hosts,
which analyzed weeks after cell transfer. All numbers percent of nucleated cells in each organ.
mAb t (Stall and Loken, 1984), t (Sieckman et al., 1991), 6a, (Stall and Loken, 1984), B220 (Coffman and Weissman, 1981; Kincade et al., 1981).
Negative control: Cells staining with secondary antibody only.
fetuses had been cultured for 20 days and increased
100-fold when the culture period was increased by
1 week of culture (Table 1, Experiments I and II).
There were also even fewer host B cells in the
periphery.
Interestingly, the reduction in peripheral, host B
cells observed when long-term cultured ES fetuses
were used as the source of cells was also observed
when chimeric bone marrow cells from the first host
were transferred to secondary hosts. After the trans-
fer of chimeric bone marrow cells, ES-derived B cells
migrated preferentially to lymph nodes and spleen
of the second host, that is, the percentage of host B
cells was much less than in unimplanted control
mice. This type of reduction was observed with both
ES-cell lines used, CCE line and D3 (Table 1).
T Lymphocytes and Myeloid Cells of Donor
and Host Origin Are Present in Chimeric Nude
Mice
To document the differentiation of T lymphocytes
and other cell types, ES fetuses were implanted
subcutaneously into Balb/c nude mice. Host and
donor cells can be distinguished by a haplotypic
difference in surface MHC class I antigens. Three
weeks after implantation, single-cell suspensions
from bone marrow, lymph nodes, and spleen of
chimeric mice were stained with FITC-labeled
mAbs specific for the H-2K
b and H-2Dd antigens
of cells derived from donor and host, respectively.
In addition, cells from each experiment were ana-
lyzed for expression of several T-cell markers
(CD4, CD8, a,8 TCR), B-cell markers (sIg, B220,
and GP-76) as well as a marker of cells of the
myeloid lineage (Mac-l). The proportion of cells
positive with each surface marker in lymph nodes
and spleen was estimated by flow cytometry. The
percentages of cells positive for these markers
among donor- and host-derived cells are summa-
rized in Table 2.
in most experiments, sIg /, B220 mature B cells
were present, as well as GP-76 pre-B cells (Strasser,
1988). Mac-1
/ myeloid cells were also present in all
experiments. A small but significant number of cells
expressed CD4, CD8, and a,8 TCR T cells of both
donor and host origin. In lymph nodes, we detected
a few CD4 /8
/ double-positive T cells of donor
origin (data not shown). These double-positive T
cells most likely account for the total percentage of
cells found in experiments in Table 2, exceeding the
theoretical maximum value. Thus, precursor B, B,
and T cells, as well as myeloid cells, developed in
the chimeric mice.82 U. CHEN and H. MOK
TABLE 2
Lymphoid and Myeloid Cells of Donor and Host Origin in Chimeric Mice"
Expt. Origin/conditions/ Organ GP-76 sIg B220 Mac-1 cTCR CD4 CD8
no. anti-class mAb
Ia ES fetuses of line D3 LN 5.6 9.9 10.2 4.4 7.3 6.7 4.5
culturedr 19 da.y Spleen 6.1 6.5 5.4 6.0 6.5 2.2 1.3
anti-H-2K (donor
Ib ES fetuses of line D3 LN 30.1 63.1 54.1 13.2 13.4 11.7 8.5
cultured for 19 days Spleen 15.2 39.5 25.7 43.6 18.7 8.7 17.4
anti-H-2Da (host)
IIa Balb/c nu/nu mice LN 0.1 0.7 0.6 0.4 0.7 0.1 0.1
anti-H-2K (control) Spleen 0.5 0.2 0.1 0.2 0.2 0.1 0.1
IIb Balb/c nu/nu mice LN n.d. n.d. n.d. n.d. n.d. n.d. n.d.
anti-H-2Da (control) Spleen 0.5 56.3 56.6 3.1 9.5 2.0 2.3
III Strain 129 mice LN 7.3 45.6 50.6 1.6 46.5 40.0 8.1
anti-H-2Kb (control) Spleen 1.9 50.7 54.4 2.6 25.3 32.2 7.6
ES fetuses implanted into Balb/c nude mice; three weeks later cells analyzed by flow cytometry. All numbers percent of nucleated cells in each organ.
H-2 K MHC class of donor origin reacting with mAb B8-24-3 (K6hler et al. 1981); H-2Dd: MHC class of host origin reacting with mAb 15.5.5 (Ozato et al., 1980).
mAb GP-76 (Strasser, 1988), B220 (Coffman and Weissman, 1981; Kincade et al., 1981), Mac-1 (Springer et al., 1979), a[TCR (Kubo et al., 1989), CD4 (Wilde et al., 1983),
CD8 (Ledbetter and Herzenberg, 1979).
n.d.: not done.
DISCUSSION
It should be emphasized that the results to be
reported here, like those reported earlier (Chen
etal., 1992), can only be obtained when "ES
fetuses"--embryoid bodies selected-for the presence
of the cup-shaped structures containing lymphocyte
precursors--are used. For the present experiments,
we have implanted the cultured ES fetuses subcu-
taneously rather than under the kidney capsule
implantation because it is simpler and faster; the
operation takes about 1 min. instead of 30 min.
Moreover, the space for implantation of embryoid
bodies is larger; 10 bodies can be implanted at one
site instead of one or two. It is also likely that cell
migration is easier without the capsule.
Lymphocytes of Donor and Host Origin are
Present in Chimeric Nude Mice
Depending on the strain combination of chimerism,
we could follow the maturation and migration of B
cells only in 129 (ES)-C57B1/6 chimeric nude mice
or donor T and B cell in 129 (ES)-Balb/c chimeric
mice. As summarized in Table 1, a high ratio of B
cells of donor vs. host in the chimeric nude mice was
detected in this study, and the total amount of sIg
was comparable to the values found in control mice.
This phenomenon could be due to any or all of the
following: (a) ES-derived B cells proliferate faster
than host B cells and thus take over the peripheral
B-cell pool. (b) ES-derived cells were activated non-
specifically either in prolonged culture or in chimeric
bone marrow so that they were primed to suppress
host B cells. (c) Donor cells that actively suppress the
host B cells may not be B cells or precursor B cells.
The presence of mature T cells, shown in Table 2,
implies thymic function of the implant to allow the
education of mature CD4 and CD8
/ T cells (re-
view by von Boehmer, 1990; von Boehmer and
Rajewsky, 1993). Because there was a quantitative
increase of T cells of host origin after ES fetus
implantation, the implant seemed to also function as
a thymus for extrinsic host cells.
Quo Vadis?
As we were able to obtain cells of various lineages at
relatively high frequencies after implantation of the
cystic embryoid bodies that we call ES fetuses, it
might be possible to also obtain untransformed,
committed lineage-specific stem cells for many pur-
poses. This would provide us with a way to dissect
the development of lineage-specific stem cells. In
addition, such a study could have practical applica-
tions in understanding some complications that
occur during the repopulation of immunodeficient
mice with transferred lymphocytes from embryonic
sources.
Because the time needed for one experiment of in
vitro formation of ES fetus and in vivo differentia-
tion to mature lymphoid or myeloid cells is 7 weeks,
the method described in this study may serve as a
shortcut for studying the expression of lymphoid-
specific genes in both embryonic and adult stagesUNTRANSFORMED ES LYMPHOCYTES 83
after mutation or transfection of genes in ES cells
(Chen et al., manuscript in preparation).
MATERIALS AND METHODS
Culture of ES Cells and the Differentiation of
Embryoid Bodies
Male ES cells (ES-D3) (Doetschman et al., 1985;
Gossler et al., 1986) of strain 129 origin were a gift
from Rolf Kemler, Max Planck Institute for Immu-
nobiology, Freiburg, Germany. Male ES cells (ES-
CCE) (Robertson, 1987) of strain 129 were a kind
gift from Elizebeth Robertson and Fred Alt, Harvard
University. Undifferentiated ES-cell lines were
grown on embryonic feeder cells in DMEM supple-
mented with 15% heat-inactivated, preselected fetal
calf serum. After reaching confluence, the ES cells
were allowed to differentiate in a suspension culture
for 36 days (Chen, 1992). Briefly, about 1-2 x 105 ES
cells were inoculated into ES differentiation medium
(i.e., DMEM, supplemented with 15% preselected,
heat-inactivated FCS, 10
4 M 2-mercaptoethanol
and antibiotics) without feeder cells into a 60 x 15
mm hydrophobic culture dish (Heraeus, Heusen-
stamm, Germany). The cultures were kept at 37C
in a humidified incubator with air and 5% CO2 and
the medium was changed daily for 36 days. Within
4-5 days, the cell clusters expanded three-
dimensionally such that simple embryoid bodies
could be observed. Complicated structures, for ex-
ample, pulsating cardiac muscle, and yolk sac blood
islands, developed inside some of the bodies after
another 4-5 days. At this stage of development, the
structures are called cystic embryoid bodies (Doet-
schman et al., 1985; Robertson, 1987). At the same
time or slightly after the appearance of cardiac
muscle and blood islands, some cystic embryoid
bodies developed a cup-shaped structure containing
lumphoidlike cells (Chen et al., 1992). Such ES
fetuses were taken for implantation at day 11-12,
day 17-18, day 25-26, and day 35-36 of culture.
Implantation of ES Fetuses into Adult Mice
Four- to six-week-old male nu/nu C57B1/6 mice
and nu/nu Balb/c mice were used as hosts. This
was performed with mice uder general anesthesia
administered by intraperitoneal injection of Avertin
(8 mg per 0.4 ml per 10 grams of body weight;
Ardreich, Steinheim, Germany). Ten mice per group
received implants subcutaneously in the lumbar
region superficial to the spinal column using general
surgical procedures. Three weeks post surgery, most
of the mice were sacrificed. Organs and tissues were
removed and prepared for cryostat sectioning and
for flow cytometry assays (Chen and Kosco, 1993).
For animal experiments, fhe experimental license
number is Bewilligung-714 of the Basel Institute for
Immunology.
Characterization of Lymphoid and Myeloid Cell
Populations by Flow Cytometry
In C57B1/6 chimeras, B cells of donor and host
origins were distinguished by the IgM and IgD
allotype expressed on the surface of B cells--# and
(a, or//b and cb, for donor and host, respectively. In
Balb/c chimeras, lymphoid and myeloid popula-
tions of donor and host origin were distinguished by
the MHC class I antigen--H-2K
b and H-2D
d for
donor and host, respectively. The mAbs used were
biotin-labeled B8-24-3 (anti-H-2Kb; K6hler et al.,
1981) and Texas Red-labeled streptavidin (Southern
Biotechnology, Birmingham), and biotin-labeled
15.5.5 (anti-H-2Dd; Ozato et al., 1980, 1985), and
Texas Red-labeled streptavidin. In addition, FITC-
labeled goat anti-mouse /-chain F(ab) (Silenus,
Hawthorotreet, Australia). Secondary reagents in-
cluded FITC-labeled rabbit anti-hamster IgG F(ab),
sheep anti-mouse Ig (heavy and light chains) F(ab).
Immunofluorescence was evaluated by flow cytom-
etry. Gating of lymphocytes was performed accord-
ing to the FACS Lysis II program as described in
detail in the manual by Becton-Dickinson; a similar
gating method has been previously used by Chen
(1992). The standard deviation of values in Tables 1
and 2 was 2%.
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